The efficacy of medical masks and respirators against respiratory infection in healthcare workers
Open Access
- 30 August 2017
- journal article
- clinical trial
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 11 (6), 511-517
- https://doi.org/10.1111/irv.12474
Abstract
We aimed to examine the efficacy of medical masks and respirators in protecting against respiratory infections using pooled data from two homogenous randomised control clinical trials (RCTs). The data collected on 3591 subjects in two similar RCTs conducted in Beijing, China, which examined the same infection outcomes, were pooled. Four interventions were compared: (i) continuous N95 respirator use, (ii) targeted N95 respirator use, (iii) medical mask use and (iv) control arm. The outcomes were laboratory-confirmed viral respiratory infection, influenza A or B, laboratory-confirmed bacterial colonisation and pathogens grouped by mode of transmission. Rates of all outcomes were consistently lower in the continuous N95 and/or targeted N95 arms. In adjusted analysis, rates of laboratory-confirmed bacterial colonisation (RR 0.33, 95% CI 0.21-0.51), laboratory-confirmed viral infections (RR 0.46, 95% CI 0.23-0.91) and droplet-transmitted infections (RR 0.26, 95% CI 0.16-0.42) were significantly lower in the continuous N95 arm. Laboratory-confirmed influenza was also lowest in the continuous N95 arm (RR 0.34, 95% CI 0.10-1.11), but the difference was not statistically significant. Rates of laboratory-confirmed bacterial colonisation (RR 0.54, 95% CI 0.33-0.87) and droplet-transmitted infections (RR 0.43, 95% CI 0.25-0.72) were also lower in the targeted N95 arm, but not in medical mask arm. The results suggest that the classification of infections into droplet versus airborne transmission is an oversimplification. Most guidelines recommend masks for infections spread by droplets. N95 respirators, as “airborne precautions,” provide superior protection for droplet-transmitted infections. To ensure the occupational health and safety of healthcare worker, the superiority of respirators in preventing respiratory infections should be reflected in infection control guidelines.Keywords
Funding Information
- Australian National Health & Medical Research Council of Australia (630787)
This publication has 15 references indexed in Scilit:
- Facemasks for the prevention of infection in healthcare and community settingsBMJ, 2015
- Uncertainty, risk analysis and change for Ebola personal protective equipment guidelinesInternational Journal of Nursing Studies, 2014
- Availability, consistency and evidence-base of policies and guidelines on the use of mask and respirator to protect hospital health care workers: a global analysisBMC Research Notes, 2013
- Exposure to Influenza Virus Aerosols During Routine Patient CareThe Journal of Infectious Diseases, 2013
- Indirect and mixed‐treatment comparison, network, or multiple‐treatments meta‐analysis: many names, many benefits, many concerns for the next generation evidence synthesis toolResearch Synthesis Methods, 2012
- A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workersInfluenza and Other Respiratory Viruses, 2011
- Measurements of Airborne Influenza Virus in Aerosol Particles from Human CoughsPLOS ONE, 2010
- Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: A randomized controlled trialAmerican Journal of Infection Control, 2009
- 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care SettingsAmerican Journal of Infection Control, 2007
- Bacteriologic Procedures in the Evaluation of Methods for Control of Air-borne InfectionAmerican Journal of Public Health and the Nations Health, 1946